Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspectedClostridium difficile-associated diarrhea

    loading  Checking for direct PDF access through Ovid

Abstract

The impact of a new Clostridium difficile nucleic acid amplification test (NAAT) on antibiotic utilization in patients with suspected C difficile infection was assessed. This single-center, cross-sectional study of 270 patients demonstrated that the use of NAAT decreased antibiotic expenditure by reducing prolonged empiric days of therapy in these patients.

Related Topics

    loading  Loading Related Articles